Marek Koziński

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology

Assays of different aspects of haemostasis – what do they measure?

Universal Definition of Myocardial Infarction: Clinical Insights

Oxidative stress, aging, and diseases

Fourth Universal Definition of Myocardial Infarction (2018)

Large early variation of residual platelet reactivity in Acute Coronary Syndrome patients treated with clopidogrel

Stem Cell Therapies in Clinical Trials: Progress and Challenges

Obesity and inflammation: the linking mechanism and the complications

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

The inflammatory response in myocardial infarction

Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance

Atherosclerosis

Role of homocysteine in the development of cardiovascular disease

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction

Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine

Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Vascular Injury and Repair: A Potential Target for Cell Therapies

Novel biomarkers for cardiovascular risk prediction.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Myocardial Ischemia Reperfusion Injury

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Fourth Universal Definition of Myocardial Infarction (2018)

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

What to do when you question cardiac troponin values

Fourth universal definition of myocardial infarction (2018)

Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention – is it necessary?

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Drug‐Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism

Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes

Genetic determinants of platelet response to clopidogrel

Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction

Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial

Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials

Low‐molecular‐weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST‐elevation myocardial infarction: a meta‐analysis

Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS‐PCI study

Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence

Diurnal variation in platelet inhibition by clopidogrel

European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay

Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.

The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.

Combined periprocedural evaluation of CRP and TNF-α enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions

Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.